These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 3901243)

  • 21. Evaluation of serum deoxythymidine kinase as a marker in multiple myeloma.
    Simonsson B; Källander CF; Brenning G; Killander A; Ahre A; Gronowitz JS
    Br J Haematol; 1985 Oct; 61(2):215-24. PubMed ID: 4041368
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical staging and immunological findings in chronic lymphocytic leukemia.
    Foa R; Catovsky D; Brozovic M; Marsh G; Ooyirilangkumaran T; Cherchi M; Galton DA
    Cancer; 1979 Aug; 44(2):483-7. PubMed ID: 314324
    [TBL] [Abstract][Full Text] [Related]  

  • 23. GM-CSF raises serum levels of beta 2-microglobulin and thymidine kinase in patients with chronic lymphocytic leukaemia.
    Itälä M; Pelliniemi TT; Remes K
    Br J Haematol; 1996 Jul; 94(1):129-32. PubMed ID: 8757522
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Serum bactericidal and opsonic activities in chronic lymphocytic leukemia and multiple myeloma.
    Kansu E; Akalin E; Civelek C; Tekesin O; Laleli Y; Firat D
    Am J Hematol; 1986 Nov; 23(3):191-6. PubMed ID: 3766522
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Beta 2-microglobulin in chronic lymphocytic leukaemia.
    Simonsson B; Wibell L; Nilsson K
    Scand J Haematol; 1980 Feb; 24(2):174-80. PubMed ID: 6154964
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Increase in T gamma lymphocytes in B-cell chronic lymphocytic leukaemia. II. Correlation with clinical stage and findings in B-prolymphocytic leukaemia.
    Catovsky D; Lauria F; Matutes E; Foa R; Mantovani V; Tura S; Galton DA
    Br J Haematol; 1981 Apr; 47(4):539-44. PubMed ID: 6971120
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Lipoprotein lipase and serum thymidine kinase level in chronic lymphocytic leukemia and their correlations with other prognostic factors].
    Xu W; Shen QD; Yu H; Qiao C; Wu YJ; Liu Q; Zhu DX; Miao KR; Li JY
    Zhonghua Xue Ye Xue Za Zhi; 2009 Jan; 30(1):8-12. PubMed ID: 19563027
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Direct effect of interleukin 2 on chronic lymphocytic leukaemia B cell functions and morphology.
    Malkovska V; Murphy J; Hudson L; Bevan D
    Clin Exp Immunol; 1987 Jun; 68(3):677-84. PubMed ID: 3115651
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Impaired synthesis of immunoglobulin in patients with chronic lymphocytic leukemia.
    Kurec AS; Davey FR
    Am J Hematol; 1987 Jun; 25(2):131-42. PubMed ID: 2955695
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Partial characterization and identification of chemokinetic factors in serum.
    Håkansson L; Venge P
    Scand J Immunol; 1983 Dec; 18(6):531-7. PubMed ID: 6198716
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Monoclonal Bence Jones proteinuria in chronic lymphocytic leukaemia.
    Pezzoli A; Pascali E
    Scand J Haematol; 1986 Jan; 36(1):18-24. PubMed ID: 3952462
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Serum immunoglobulins and lymphocyte subsets in chronic lymphocytic leukemia.
    Davey FR; Kurec AS; Tomar RH; Smith JR
    Am J Clin Pathol; 1987 Jan; 87(1):60-5. PubMed ID: 2948384
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Flow cytometric analysis of T-lymphocyte subpopulations in B-cell chronic lymphocytic leukemia: correlation with clinical stage.
    Hautekeete ML; De Bock RF; Van Bockstaele DR; Colpin GC; Berneman ZN; Peetermans ME
    Blut; 1987 Nov; 55(5):447-52. PubMed ID: 3499946
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Serum paraproteins in chronic lymphocytic leukaemia.
    Sinclair D; Dagg JH; Mowat AM; Parrott DM; Stott DI
    J Clin Pathol; 1984 Apr; 37(4):463-6. PubMed ID: 6707229
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Impaired low-density lipoprotein receptor activity in chronic B-lymphocytic leukaemia cells.
    Juliusson G; Vitols S
    Eur J Haematol; 1988 Jan; 40(1):18-24. PubMed ID: 3257738
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Biochemical characteristics of chronic lymphocytic leukaemia. Glucocorticoid receptors, B and T lymphocyte surface markers, concanavalin A-induced agglutination and thymidine incorporation.
    Simonsson B; Nilsson K; Terenius L; Glimelius B
    Scand J Haematol; 1978 Nov; 21(5):379-89. PubMed ID: 310576
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Kinetic studies on lymphocytes labelled with indium 111-oxine in patients with chronic lymphocytic leukaemia.
    Matsuda S; Uchida T; Kariyone S
    Scand J Haematol; 1985 Aug; 35(2):210-8. PubMed ID: 3931210
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Induction of proliferation and Ig production in human B leukemic cells by anti-immunoglobulins and T cell factors.
    Yoshizaki K; Nakagawa T; Kaieda T; Muraguchi A; Yamamura Y; Kishimoto T
    J Immunol; 1982 Mar; 128(3):1296-301. PubMed ID: 6799573
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Serum TK levels in CLL identify Binet stage A patients within biologically defined prognostic subgroups most likely to undergo disease progression.
    Matthews C; Catherwood MA; Morris TC; Kettle PJ; Drake MB; Gilmore WS; Alexander HD
    Eur J Haematol; 2006 Oct; 77(4):309-17. PubMed ID: 16856923
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Monoclonal and oligoclonal immunoglobulins in the serum of patients with B-chronic lymphocytic leukemia.
    Pangalis GA; Moutsopoulos HM; Papadopoulos NM; Costello R; Kokkinou S; Fessas P
    Acta Haematol; 1988; 80(1):23-7. PubMed ID: 3135689
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.